Found: 32
Select item for more details and to access through your institution.
The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know?
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1838, doi. 10.3390/cancers16101838
- By:
- Publication type:
- Article
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e244435, doi. 10.1001/jamanetworkopen.2024.4435
- By:
- Publication type:
- Article
Postoperative Outcomes of Pre-Pectoral Versus Sub-Pectoral Implant Immediate Breast Reconstruction.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1129, doi. 10.3390/cancers16061129
- By:
- Publication type:
- Article
Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the "Sentinel Envahi et Randomisation du Curage" SERC Trial.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1198, doi. 10.3390/cancers16061198
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6930
- By:
- Publication type:
- Article
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1287253
- By:
- Publication type:
- Article
Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4567, doi. 10.3390/cancers15184567
- By:
- Publication type:
- Article
The MonarchE trial: improving the clinical outcome in HR<sup>+</sup>/HER2<sup>−</sup> early breast cancer: recent results and next steps.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 938, doi. 10.1002/cac2.12466
- By:
- Publication type:
- Article
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer.
- Published in:
- Cancer Communications, 2023, v. 43, n. 8, p. 943, doi. 10.1002/cac2.12447
- By:
- Publication type:
- Article
RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 6, p. 762, doi. 10.1093/jnci/djad060
- By:
- Publication type:
- Article
Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer.
- Published in:
- Osteoporosis International, 2023, v. 34, n. 4, p. 703, doi. 10.1007/s00198-023-06683-0
- By:
- Publication type:
- Article
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 938, doi. 10.3390/pharmaceutics15030938
- By:
- Publication type:
- Article
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4023, doi. 10.1002/cam4.5257
- By:
- Publication type:
- Article
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 10, p. 1, doi. 10.15252/emmm.202215859
- By:
- Publication type:
- Article
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143356
- By:
- Publication type:
- Article
RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.
- Published in:
- 2022
- By:
- Publication type:
- editorial
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 3, p. 1, doi. 10.3802/jgo.2022.33.e31
- By:
- Publication type:
- Article
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1306, doi. 10.3390/cancers14051306
- By:
- Publication type:
- Article
Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1683, doi. 10.3390/curroncol29030140
- By:
- Publication type:
- Article
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 932, doi. 10.3390/cancers14040932
- By:
- Publication type:
- Article
WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer.
- Published in:
- Advanced Science, 2021, v. 8, n. 17, p. 1, doi. 10.1002/advs.202101030
- By:
- Publication type:
- Article
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2807, doi. 10.3390/cancers13112807
- By:
- Publication type:
- Article
Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Adjuvant chemotherapy for small, lymph node-negative, triple-negative breast cancer: A single-center study and a meta-analysis of the published literature.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1158, doi. 10.3390/cancers11081158
- By:
- Publication type:
- Article
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 2, p. 379, doi. 10.1007/s10549-019-05160-9
- By:
- Publication type:
- Article
Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 432, doi. 10.3390/cancers11030432
- By:
- Publication type:
- Article
Medical staff opposition to a deep and continuous palliative sedation request under Claeys-Leonetti law.
- Published in:
- BMC Palliative Care, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12904-018-0384-3
- By:
- Publication type:
- Article
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 1, p. 111, doi. 10.1007/s10549-018-4944-2
- By:
- Publication type:
- Article
Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care.
- Published in:
- BMC Palliative Care, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12904-018-0357-6
- By:
- Publication type:
- Article
Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center.
- Published in:
- 2017
- By:
- Publication type:
- journal article
End-of-Life Practices in France under the Claeys-Leonetti Law: Report of Three Cases in the Oncology Unit.
- Published in:
- Case Reports in Oncology, 2016, v. 9, n. 3, p. 650, doi. 10.1159/000450940
- By:
- Publication type:
- Article